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The utility of serum glucose measurement 
at 1 hour of the oral glucose tolerance test
AbsTrAcT
The oral glucose tolerance test (OGTT) is performed in 
patients in whom abnormalities of glucose metabolism 
are suspected, but the criteria for diagnosing diabetes 
are not yet met. It is also routinely carried out in the 
management of diseases associated with a more or 
less pronounced disturbance of glucose intolerance. 
According to the current guidelines, during OGTT 
glycemia is measured before and two hours after 
the administration of glucose. In pregnancy, three 
measurements are obligatory (0’, 60’, 120’). When ad-
ditional indications are present, glycemia is assessed 
also 30 minutes after the administration of glucose 
and when reactive hypoglycemia is suspected, the test 
is extended to 180 minutes. As of late, it is becoming 
a more and more common practice to measure blood 
glucose also 60 minutes post-administration. This tech-
nique is more reliable for the assessment of glucose 
tolerance disturbance. It seems sensible to introduce 
a recommendation of such measurement as a routine 
practice. (clin Diabetol 2016; 5, 4: 127–130)
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Introduction
The criteria for diagnosing diabetes are established. 
According to the current guidelines, a random plasma 
glucose ≥ 200 mg/dL (11.1 mmol/L) is sufficient enough 
to diagnose this disease [1, 2]. In 2003, the American 
Diabetes Association defined the threshold for the 
identification of IFG (impaired fasting glucose) at 
100 mg/dL (5.6 mmol/L) — and those recommendations 
are still valid [3].
A recognition of other disorders is an indication 
for additional investigations. A basic test for identify-
ing the level of glucose metabolism impairment is the 
oral glucose tolerance test (OGTT). The measurement of 
glycemia is carried out before the oral administration of 
glucose and then, based on the WHO recommendations 
from the year 1999, at 2 hours post-administration. The 
test has undergone modifications over the years and 
thus, for example, during pregnancy it is obligatory 
to perform three glucose measurements at 0, 60 and 
120 minutes [2, 4].
In the case of special indications (simultaneous 
insulin secretion assessment), glycemia is also measured 
at 30 minutes post glucose administration. If reactive 
hypoglycemia is being diagnosed, the test is prolonged 
to 180 minutes. The OGTT is performed in patients 
with confirmed impairment of glucose metabolism or 
in whom such impairment is suspected — if the typi-
cal criteria for diagnosing diabetes are not met. This 
includes patients with IFG (impaired fasting glucose 
— glycemia in the 100–125 mg/dL or 5.6–6.9 mmol/L 
range) or IGT (impaired glucose tolerance — glycemia 
at 2 hours of OGTT in the 140–199 mg/dL or 7.8–11.1 
mmol/L range) [5].
The American authors presented interesting re-
search in which it was pointed out that the recognition 
of IFG in children can be considered a forecast of type 2 
diabetes in adolescence [6].
OGTT is also routinely performed in states, in 
which concomitant glucose intolerance may be present 
(endocrine disorders, pancreatic diseases, genetic syn-
dromes, use of medication known to impair glucose 
metabolism). 
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In practice, it is more and more common to routine-
ly measure glycemia also at the 60 minute mark of the 
OGTT [7]. This gives a more reliable basis for the assess-
ment of glucose tolerance impairment. There have been 
reports to suggest, that such modification of the OGTT 
is useful especially in the prognosis of the development 
of type 2 diabetes [8–10]. The Authors, after analyzing 
data from 7–8 years, concluded that the measurement 
of glycemia at 1 hour of OGTT is a better predictor of 
type 2 diabetes risk that the classic assessment at 2 
hours. Similar observations concerning the 1-hour post 
administration measurement were reported by differ-
ent authors [11]. In particular, Italian authors studied 
the importance of early OGTT measurement for the 
prediction of diabetes development in children [12]. 
They set the 1-hour OGTT threshold for recognizing dia-
betes risk in juvenile obese patients at ≥ 132.5 mg/dL 
(≥ 7.4 mmol/L). The Chinese authors reported a higher 
risk of metabolic disorders if 1-hour OGTT value was 
≥ 154.8 mg/dL (≥ 8.6 mmol/L) [13]. Similar prediction 
thresholds for 1-hour OGTT were reported by other 
researchers [14].
Recently, results have been published on the rela-
tionship between 1-hour OGTT values, the assessment 
of beta-cell function and insulin sensitivity [15].
Italian authors published research on the risk of 
renal dysfunction and its association with early OGTT 
measurement values [16].
The border 1-hour post-load value for recogniz-
ing increased risk of metabolic syndrome was recently 
established at 158.4 mg/dL (8.85 mmol/L) [17].
Clinical cases
Below are a few clinical examples which illustrate 
the importance of 1-hour post-load OGTT measure-
ment for the prognosis of diabetes development 
(Tab. 1–6).
Discussion 
An analysis of the cases presented above suggests 
an exceptional utility of 1-hour post-load OGTT meas-
urement. It is important to notice that due to the lack 
of established reference values for such measurement, 
its results are often ignored which delays the introduc-
tion of adequate treatment [2].
It seems that the assessment of early OGTT values 
would, in many cases, provide an indication for the 
beginning of therapy. 
Conclusion
More and more authors point out to the utility of 
1 hour post-load OGTT glucose measurement in prog-
nosing the development of type 2 diabetes, cardio-
vascular diseases, renal failure and other disorders in 
patients who do not fulfill the criteria for diagnosing 
diabetes. The literature on this subject is abundant. 
Table 1. case 1 — male patient with symptoms of metabolic syndrome; age 59 years
Time of measurement Pre-load OGTT 
[mg/dL (mmol/L)]
1 hour post-load 
[mg/dL (mmol/L)]
2 hours post-load 
[mg/dL (mmol/L)]
subsequent therapy
Baseline 78 (4.3) 194 (10.8) 142 (7.9) No treatment
After 9 years 136 (7.6) 244 (13.6) 147 (8.2) No treatment
After 11 years 149 (8.3) 338 (18.8) 280 (15.6) Treatment: diet, increased 
physical activity,  
metformin, liraglutide
After 3 months of therapy 94 (5.2) 181 (10.0) 150 (8.3) Continued liraglutide,  
metformin
Table 2. case 2 — male patient with symptoms of metabolic syndrome; age 48 years
Time of measurement Pre-load OGTT 
[mg/dL (mmol/L)]
1 hour post-load 
[mg/dL (mmol/L)]
2 hours post-load 
[mg/dL (mmol/L)]
subsequent therapy
Baseline 100 (6.1) 211 (11.7) 85 (4.7) No treatment
After 1 year 103 (5.7) 209 (11.6) 161 (8.9) No treatment
After 3 years 122 (6.8) 224 (12.4) 169 (9.4) Treatment: diet, increased 
physical activity, metformin, 
incretin mimetic
Ewa Otto-Buczkowska, Marek Dryżałowski, Utility of glucose measurement at 1 hour of OGTT
129
In this situation it would seem reasonable to include 
an obligatory 1 hour post-load glucose measurement 
in every case when OGTT is performed.
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